Literature DB >> 17445960

ISG20, an actor of the innate immune response.

Genevieve Degols1, Patrick Eldin, Nadir Mechti.   

Abstract

The interferon (IFN) system is a major effector of the innate immunity that allows time for the subsequent establishment of an adaptive immune response against wide-range pathogens. The effectiveness of IFN to control initial infection requires the cooperation between several pathways induced in the target cells. Recent studies that highlight the implication of the 3'-5' exonuclease ISG20 (IFN Stimulated Gene product of 20 kDa) in the host's defenses against pathogens are summarised in this review.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17445960     DOI： 10.1016/j.biochi.2007.03.006

Source DB:  PubMed          Journal:  Biochimie        ISSN： 0300-9084            Impact factor:   4.079


  26 in total

Review 1.  Interferon-stimulated gene 20-kDa protein (ISG20) in infection and disease: Review and outlook.

Authors:  Zhiwei Zheng; Lin Wang; Jihong Pan
Journal:  Intractable Rare Dis Res       Date:  2017-02

2.  Estradiol and proinflammatory cytokines stimulate ISG20 expression in synovial fibroblasts of patients with osteoarthritis.

Authors:  Zhiwei Zheng; Lin Wang; Jihong Pan
Journal:  Intractable Rare Dis Res       Date:  2017-11

3.  Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol.

Authors:  Su-Yang Liu; Roghiyh Aliyari; Kelechi Chikere; Guangming Li; Matthew D Marsden; Jennifer K Smith; Olivier Pernet; Haitao Guo; Rebecca Nusbaum; Jerome A Zack; Alexander N Freiberg; Lishan Su; Benhur Lee; Genhong Cheng
Journal:  Immunity       Date:  2012-12-27       Impact factor: 31.745

Review 4.  Measure and countermeasure: type I IFN (IFN-alpha/beta) antiviral response against West Nile virus.

Authors:  Stephane Daffis; Mehul S Suthar; Michael Gale; Michael S Diamond
Journal:  J Innate Immun       Date:  2009-06-24       Impact factor: 7.349

Review 5.  The yin and yang of hepatitis C: synthesis and decay of hepatitis C virus RNA.

Authors:  You Li; Daisuke Yamane; Takahiro Masaki; Stanley M Lemon
Journal:  Nat Rev Microbiol       Date:  2015-08-10       Impact factor: 60.633

6.  TREX1 acts in degrading damaged DNA from drug-treated tumor cells.

Authors:  Chuan-Jen Wang; Wing Lam; Scott Bussom; Hua-Mei Chang; Yung-Chi Cheng
Journal:  DNA Repair (Amst)       Date:  2009-07-18

Review 7.  Innate immune responses in hepatitis C virus infection.

Authors:  Kui Li; Stanley M Lemon
Journal:  Semin Immunopathol       Date:  2012-08-07       Impact factor: 9.623

8.  Antiviral activities of ISG20 in positive-strand RNA virus infections.

Authors:  Zhi Zhou; Nan Wang; Sara E Woodson; Qingming Dong; Jie Wang; Yuqiong Liang; Rene Rijnbrand; Lai Wei; Joan E Nichols; Ju-Tao Guo; Michael R Holbrook; Stanley M Lemon; Kui Li
Journal:  Virology       Date:  2010-10-30       Impact factor: 3.616

9.  Interferon regulatory factor-1 (IRF-1) shapes both innate and CD8(+) T cell immune responses against West Nile virus infection.

Authors:  James D Brien; Stephane Daffis; Helen M Lazear; Hyelim Cho; Mehul S Suthar; Michael Gale; Michael S Diamond
Journal:  PLoS Pathog       Date:  2011-09-01       Impact factor: 6.823

10.  Induction of IFN-beta and the innate antiviral response in myeloid cells occurs through an IPS-1-dependent signal that does not require IRF-3 and IRF-7.

Authors:  Stephane Daffis; Mehul S Suthar; Kristy J Szretter; Michael Gale; Michael S Diamond
Journal:  PLoS Pathog       Date:  2009-10-02       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.